TRxADE Health
(NASDAQ) MEDS
TRxADE Health Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$653.39K
Net Income (TTM)
$20.73M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MEDS News
MEDS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout TRxADE Health
Industry
Internet and Direct Marketing Retail
Sector
Consumer DiscretionaryEmployees
19
CEO
Shankar Hariharan, PhD; Narasimhan Mani, PhD, MBA
Website
www.scienture.comHeadquarters
Land O'Lakes, FL 34639, US
MEDS Financials
Key Financial Metrics (TTM)
Gross Margin
90%
Operating Margin
-33%
Net Income Margin
-32%
Return on Equity
-26%
Return on Capital
-22%
Return on Assets
-20%
Earnings Yield
N/A
Dividend Yield
125.16%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$6.00K
Operating Income
$18.78M
EBITDA
$18.78M
Operating Cash Flow
$13.29M
Capital Expenditure
$0.00
Free Cash Flow
$13.29M
Cash & ST Invst.
$308.10K
Total Debt
$3.12M
TRxADE Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$590.05K
+809.7%
Gross Profit
$574.62K
+14698.4%
Gross Margin
97.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
8
N/A
Net Income
$3.61M
-13.3%
EBITDA
$1.80M
+39.0%
Quarterly Fundamentals
Net Cash
$1.67M
+23.3%
Accounts Receivable
$652.55K
-85.6%
Inventory
$234.52K
+2874.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.02M
+521.1%
Return on Assets
-19.77%
N/A
Return on Invested Capital
-22.24%
N/A
Free Cash Flow
$3.21M
+40.6%
Operating Cash Flow
$3.21M
+40.5%